| Financial Year |
March 31 2023 |
| Monetary Funds |
1,156,123,268.91 |
| Held-for-trading Financial Assets |
2,257,644,908.80 |
| Notes Receivable |
3,200,000.00 |
| Accounts Receivable |
353,843,510.17 |
| Advances to Suppliers |
64,112,431.67 |
| Other Receivables |
55,360,890.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
13,300,085,261.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
426,689,850.66 |
| Total Current Assets |
18,389,085,228.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
16,206,196,673.73 |
| Investment Properties |
501,642,805.45 |
| Fixed Assetes |
180,335,470.18 |
| Under-construction Projects |
1,798,696.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
41,312,069.18 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,944,164.79 |
| Deferred Income Tax Assets |
217,872,818.18 |
| Other Non-Current Assets |
182,239,507.26 |
| Sub-Total of Non-Current Assets |
18,779,427,541.42 |
| Total Assets |
37,168,512,770.35 |
| Short-Term Loans |
5,256,090,986.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
27,200,000.00 |
| Accounts Payable |
4,860,034,596.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
350,792,685.25 |
| Taxes Payable |
190,908,203.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
557,001,156.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
321,189,407.15 |
| Other Current Liabilities |
2,140,674,329.78 |
| Sub-Total of Current Liabilities |
16,832,289,343.19 |
| Long-term Loans |
346,400,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,652,720,398.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,022,239,322.66 |
| Total Liabilities |
18,854,528,665.85 |
| Paid-In Capital(Or Share Stock) |
1,730,339,644.00 |
| Capital Surplus |
122,918,165.85 |
| Surplus Reserve |
1,804,384,703.80 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
13,638,538,705.60 |
| Minority Stockholder's Interest |
1,098,075,077.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,215,909,027.02 |
| Owner's Equity（Stockholder's Equity） |
18,313,984,104.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
37,168,512,770.35 |
